Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations

Karamanos, 1994, Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography, Anal. Biochem., 221, 189, 10.1006/abio.1994.1396 Fransson, 1990, A method for the sequence analysis of dermatan sulphate, Biochem. J., 269, 381, 10.1042/bj2690381 Sugahara, 2003, Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate, Curr. Opin. Struct. Biol., 13, 612, 10.1016/j.sbi.2003.09.011 Sugahara, 2000, Structure and function of oversulfated chondroitin sulfate variants: Unique sulfation patterns and neuroregulatory activities, Trends Glycosci. Glycotechnol., 12, 321, 10.4052/tigg.12.321 Theocharis, 1999, Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level, Atherosclerosis, 145, 359, 10.1016/S0021-9150(99)00117-3 Noulas, 2004, Variations in content and structure of glycosaminoglycans of the vitreous gel from different mammalian species, Biomed. Chromatogr., 8, 457, 10.1002/bmc.336 Lamari, 2006, Structure of chondroitin sulfate, Adv. Pharmacol., 53, 33, 10.1016/S1054-3589(05)53003-5 Deal, 1999, Nutraceuticals as therapeutic agents in osteoarthritis: The role of glucosamine, chondroitin sulfate, and collagen hydrolysate, Rheum. Dis Clin. North Am., 25, 379, 10.1016/S0889-857X(05)70074-0 Volpi, 2004, The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment, Curr. Drug Targets Immune Endocr. Metabol. Disord., 4, 119, 10.2174/1568008043339929 Verges, 2005, Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: A serendipitous finding, Dermatol. Online J., 11, 31, 10.5070/D32ZH8X3VF Huang, 1996, Simultaneous determination of dermatan sulfate and oversulfated dermatan sulfate in plasma by high-performance liquid chromatography with postcolumn fluorescence derivatization, Anal. Biochem., 240, 227, 10.1006/abio.1996.0352 Imanari, 1999, Oral absorption and clearance of partially depolymerized fucosyl chondroitin sulfate from sea cucumber, Thromb. Res., 93, 129, 10.1016/S0049-3848(98)00171-6 Sakai, 2002, Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine, Anal. Biochem., 302, 169, 10.1006/abio.2001.5545 Lamari, 2006, Metabolism and biochemical/physiological roles of chondroitin sulfates: Analysis of endogenous and supplemental chondroitin sulfates in blood circulation, Biomed. Chromatogr., 20, 539, 10.1002/bmc.669 Adebowale, 2000, Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials, JAMA, 3, 37 Sim, 2005, Quantitative analysis of chondroitin sulfate in raw materials, ophthalmic solutions, soft capsules, and liquid preparations, J. Chromatogr. B, 818, 133, 10.1016/j.jchromb.2004.12.015 Barnhill, 2006, Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial, J. Am. Pharm. Assoc., 46, 14, 10.1331/154434506775268616 Saad, 2005, Analysis of hyaluronan content in chondroitin sulfate preparations by using selective enzymatic digestion and electrospray ionization mass spectrometry, Anal. Biochem., 344, 232, 10.1016/j.ab.2005.06.041 Bitter, 1962, A modified uronic acid carbazole reaction, Anal. Biochem., 4, 330, 10.1016/0003-2697(62)90095-7 Liang, 2002, Development and validation of a photometric titration method for the quantitation of sodium chondroitin sulfate (bovine) in Cosequin DS chewable tablet, J. Pharm. Biomed. Anal., 28, 245, 10.1016/S0731-7085(01)00563-5 Choi, 2003, A size-exclusion HPLC method for the determination of sodium chondroitin sulfate in pharmaceutical preparations, J. Pharm. Biomed. Anal., 31, 1229, 10.1016/S0731-7085(02)00731-8 Tyler, 2002, Determination of chondroitin sulfate in raw materials by liquid chromatography, J. AOAC Intl., 85, 567 Volpi, 2007, Analytical aspects of pharmaceutical grade chondroitin sulfates, J. Pharm. Sci., 96, 3168, 10.1002/jps.20997 Foot, 2005, Classification of chondroitin sulfate A, chondroitin sulfate C, glucosamine hydrochloride, and glucosamine 6-sulfate using chemometric techniques, J. Pharm. Biomed. Anal., 38, 397, 10.1016/j.jpba.2005.01.026 Vynios, 1999, A solid-phase assay for quantitative analysis of sulfated glycosaminoglycans at the nanogram level: Application to tissue samples, J. Pharm. Biomed. Anal., 21, 859, 10.1016/S0731-7085(99)00214-9 Lamari, 2003, Derivatization of carbohydrates for chromatographic, electrophoretic, and mass spectrometric structure analysis, J. Chromatogr. B, 793, 15, 10.1016/S1570-0232(03)00362-3 Karousou, 2005, Application of polyacrylamide gel electrophoresis of fluorophore-labeled saccharides for analysis of hyaluronan and chondroitin sulfate in human and animal tissues and cell cultures, Biomed. Chromatogr, 19, 761, 10.1002/bmc.511 Volpi, 2005, Microdetermination of chondroitin sulfate in normal human plasma by fluorophore-assisted carbohydrate electrophoresis (FACE), Clin. Chim. Acta, 356, 125, 10.1016/j.cccn.2005.01.016 Karamanos, 1995, Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level: Application to analysis of tissue and cell culture proteoglycans, J. Chromatogr. A, 696, 295, 10.1016/0021-9673(94)01294-O Lamari, 1999, Ultrasensitive capillary electrophoresis of sulfated disaccharides in chondroitin/dermatan sulfates by laser-induced fluorescence after derivatization with 2-aminoacridone, J. Chromatogr. B, 730, 129, 10.1016/S0378-4347(99)00184-X Okamoto, 2004, Development of a novel analytical method for determination of chondroitin sulfate using an in-capillary enzyme reaction, J. Chromatogr. A, 1035, 137, 10.1016/j.chroma.2004.02.051 Malavaki, 2007, Hyaluronan determination: Biological significance and analytical tools, Curr. Pharm. Anal., 3, 117, 10.2174/157341207780598940 Shah, 2000, Bioanalytical method validation: A revisit with a decade of progress, Pharm. Res., 17, 1551, 10.1023/A:1007669411738 U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, USDHHS, Washington, DC, 2001. Farndale, 1982, A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures, Connect. Tissue Res., 9, 247, 10.3109/03008208209160269 Farndale, 1986, Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethylmethylene blue, Biochim. Biophys. Acta, 883, 173, 10.1016/0304-4165(86)90306-5 Harris, 2007, Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE), J. Biol. Chem., 282, 2785, 10.1074/jbc.M607787200 Pecly, 2006, Effects of molecular size and chemical structure on renal and hepatic removal of exogenously administered chondroitin sulfate in rats, Biochim. Biophys. Acta, 1760, 865, 10.1016/j.bbagen.2005.11.009 Nandini, 2006, Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors, Adv. Pharmacol., 53, 253, 10.1016/S1054-3589(05)53012-6 Merly, 2007, Induction of inflammatory cytokines by cartilage extract, Intl. Immunopharmacol., 7, 383, 10.1016/j.intimp.2006.11.011